Neo Medical, a spine company with an augmented reality platform, raised $68 million in a series B financing round, according to a Sept. 17 news release.
Funds will help boost marketing with an immediate focus on growing the U.S. business. Neo Medical focuses on thoracolumbar fusion, and its Advise AR platform leverages artificial intelligence.
Neo Medical's technologies can reduce implant failure rates by up to three times, cut infection risk by half and cut time spent in surgery by up to 29%, according to studies.
Gyrus Capital led the funding round, along with existing investors.